Multisystemic therapy for poorly adherent youth with HIV: Results from a pilot randomized controlled trial
- 22 August 2012
- journal article
- research article
- Published by Taylor & Francis Ltd in AIDS Care
- Vol. 25 (4), 507-514
- https://doi.org/10.1080/09540121.2012.715134
Abstract
Adherence to antiretroviral medication for the treatment of HIV is a significant predictor of virologic suppression and is associated with dramatic reductions in mortality and morbidity and other improved clinical outcomes for pediatric patient populations. Effective strategies for addressing adherence problems in youth infected with HIV are needed and require significant attention to the complex interplay of multiple, interacting causal risk factors that lead to poor self-care. Within the context of a pilot randomized trial, we evaluated the feasibility and initial efficacy of a multisystemic therapy (MST) intervention adapted to address HIV medication adherence problems against a usual care condition that was bolstered with a single session of motivational interviewing (MI). For 34 participating youth, health outcomes (viral load [VL] and CD4 count) were obtained from approximately 10 months pre-baseline through approximately 6 months post-baseline and self-reported medication adherence outcomes were obtained quarterly from baseline through 9 months post-baseline. Using mixed-effects regression models we examined within- and between-groups differences in the slopes of these outcomes. Feasibility was supported, with a 77% recruitment rate and near-maximal treatment and research retention and completion rates. Initial efficacy also was supported, with the MST condition but not the MI condition demonstrating statistically and clinically significant VL reductions following the start of treatment. There was also some support for improved CD4 count and self-reported medication adherence for the MST but not the MI condition. MST was successfully adapted to improve the health outcomes of youth poorly adherent to antiretroviral medications. Replication trials and studies designed to identify the mechanisms of action are important next steps.Keywords
This publication has 13 references indexed in Scilit:
- Case Study: Multisystemic Therapy for Adolescents Who Engage in HIV Transmission Risk BehaviorsJournal of Pediatric Psychology, 2009
- Adherence to Antiretroviral Therapy for Pediatric HIV Infection: A Qualitative Systematic Review With Recommendations for Research and Clinical ManagementPEDIATRICS, 2007
- The Role of Parental Monitoring in Adolescent Health Outcomes: Impact on Regimen Adherence in Youth with Type 1 DiabetesJournal of Pediatric Psychology, 2007
- Use of Multisystemic Therapy to Improve Antiretroviral Adherence and Health Outcomes in HIV-Infected Pediatric Patients: Evaluation of a Pilot ProgramAIDS Patient Care and STDs, 2006
- Measuring adherence to treatment of paediatric HIV/AIDSAIDS Care, 2005
- Assessing competence in the use of motivational interviewingJournal of Substance Abuse Treatment, 2005
- Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Nucleoside‐Analogue Reverse‐Transcriptase Inhibitors Plus Nevirapine, Nelfinavir, or Ritonavir for Pretreated Children Infected with Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 2002
- Aging cohort of perinatally human immunodeficiency virus-infected children in New York CityThe Pediatric Infectious Disease Journal, 2001
- Protease Inhibitor Therapy in HIV-Infected ChildrenAIDS Patient Care and STDs, 2000